MORGAN STANLEY - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 26 filers reported holding TSCAN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$664,184
+144.9%
259,447
+139.2%
0.00%
Q2 2023$271,188
-1.7%
108,475
-17.4%
0.00%
Q1 2023$275,770
+321.9%
131,319
+211.4%
0.00%
Q4 2022$65,371
-66.8%
42,175
-34.7%
0.00%
Q3 2022$197,000
+9.4%
64,570
+13.1%
0.00%
Q2 2022$180,000
+63.6%
57,089
+46.1%
0.00%
Q1 2022$110,000
-10.6%
39,076
+42.6%
0.00%
Q4 2021$123,000
-47.7%
27,404
-2.9%
0.00%
Q3 2021$235,00028,2360.00%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DC Funds, LP 630,000$1,612,80033.20%
Lynx1 Capital Management LP 5,224,600$13,374,9768.85%
EcoR1 Capital, LLC 5,000,000$12,800,0000.43%
Deer Management Co. LLC 1,245,505$3,188,4930.39%
Simplify Asset Management Inc. 1,046,916$2,680,1050.31%
BVF INC/IL 2,989,474$7,653,0530.21%
Alphabet Inc. 1,077,080$2,757,3240.18%
DC Investments Management, LLC 35,563$91,0410.11%
Baker Brothers Advisors 2,784,792$7,129,0680.04%
Privium Fund Management (UK) Ltd 15,825$41,4620.03%
View complete list of TSCAN THERAPEUTICS INC shareholders